Respiratory-Gated Radiotherapy Reduces Need for Repeat Planning: Presented at ELCC
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Respiratory-Gated Radiotherapy Reduces Need for Repeat Planning: Presented at ELCC

By Timothy A. O'Leary

GENEVA -- April 29, 2008 -- Use of respiratory-gated radiotherapy (RGRT) in patients with locally advanced lung cancer reduces the need to adapt or modify radiotherapy treatment plans, researchers reported here at the 1st European Lung Cancer Conference (ELCC).

Jason Pantarotto, MD, Radiation Oncologist, VU University Medical Center, Amsterdam, Netherlands, and his collaborators designed their trial to evaluate whether adaptive modification of RGRT treatment plans was needed in patients receiving concurrent chemotherapy and radiotherapy.

"Our preliminary results suggest that adaptive radiotherapy has a limited role when RGRT is used to reduce toxicity," he said in his presentation on April 25.

Eligible patients underwent a repeat planning scan after receiving 15 fractions of radiotherapy. The repeat scan was coregistered with the initial scan and a new planning target volume (PTV) was generated, he said.

Coverage of the repeat PTV was evaluated by applying the original treatment plan to the second scan and recalculating the dose. No treatment plans were modified.

"Good coverage of repeat PTVs was seen using the initial plan, with 3 patients maintaining 100% coverage by the 95% isodose volume and others showing only slight deviations [maximum volume not covered of 1.4%]," Dr. Pantarotto said. "Consequently, no treatment plans were modified. Lung and cord doses were not significantly different on the repeat scan."

He added, "The changes in PTV after 15 fractions of [chemoradiotherapy] do not appear to be clinically significant in terms of geometric or dosimetric miss."

[Presentation title: Adaptive Radiotherapy Planning During Image-Guided Concurrent CT-RT for Lung Cancer: Preliminary Analysis of a Prospective Clinical Study. Abstract 247O]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities